American College of Cardiology Annual Meeting

New research has shed light on the addition of clopidogrel to the rivaroxaban and aspirin regimen of patients with PAD. Let us know about your usual treatment course of action by taking our poll.

Are you familiar with the results of the eicosapentaenoic acid (EPA) analysis of the REDUCE-IT trial? Find out the effect of EPA on heart failure by taking our pop quiz.